Karyopharm Therapeutics Stock Forecast

Sell candidate since Jul 20, 2026 Loss -71.62%

The Karyopharm Therapeutics Inc. stock price gained 8.72% on the last trading day (Friday, 7th Aug 2026), rising from $1.95 to $2.12. During the last trading day the stock fluctuated 10.99% from a day low at $1.91 to a day high of $2.12. The price has fallen in 5 of the last 10 days and is down by -71.39% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 604 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $3.80 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.79 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -28.31% during the next 3 months and, with a 90% probability hold a price between $1.28 and $6.71 at the end of this 3-month period.

KPTI Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, August 05, 2026, and so far it has risen 10.99%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Karyopharm Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.69 and $7.76. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Karyopharm Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.97 and $1.96. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Karyopharm Therapeutics Inc. finds support just below today's level at $1.97. If this is broken, then the next support from accumulated volume will be at $1.96 and $1.92.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.210 between high and low, or 10.99%. For the last week, the stock has had daily average volatility of 10.03%.

Karyopharm Therapeutics Inc. is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KPTI) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Karyopharm Therapeutics Inc. to open at $2.05, and during the day (based on 14 day Average True Range), to move between $1.74 and $2.50, which gives a possible trading interval of +/-$0.768 (+/-44.25%) up or down from last closing price. If Karyopharm Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 44.25% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $1.97, some $0.150 (7.08%) from the current price of $2.12, our system finds the risk reward attractive.

Is Karyopharm Therapeutics Inc. stock A Buy?

Karyopharm Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.927 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $2.05 ( 3.30%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk